The Journal of Neuroscience, March 21, 2007, 27(12):3260-3267; doi:10.1523/JNEUROSCI.4033-06.2007
Previous Article | Next Article 
Neurobiology of Disease
Basic Fibroblast Growth Factor Modulates Density of Blood Vessels and Preserves Tight Junctions in Organotypic Cortical Cultures of Mice: A New In Vitro Model of the BloodBrain Barrier
Kerstin Bendfeldt,1
Vesna Radojevic,2
Josef Kapfhammer,2 and
Cordula Nitsch1
1Section of Neuroanatomy and 2Section of Neurodevelopment, Institute of Anatomy, University of Basel, CH-4056 Basel, Switzerland
Correspondence should be addressed to Dr. Kerstin Bendfeldt at the above address. Email: kerstin.bendfeldt{at}unibas.ch
This study was performed to examine the maintenance of blood vessels in vitro in cortical organotypic slice cultures of mice with special emphasis on basic fibroblast growth factor (FGF-2), which is known to promote angiogenesis and to preserve the integrity of the bloodbrain barrier. Slices of neonatal day 3 or 4 mouse brain were maintained for 3, 7, or 10 d in vitro (DIV) under standard culture conditions or in the presence of FGF-2. Immunohistochemistry for factor VIII-related antigen or laminin revealed a relative low number of blood vessels under standard conditions. In contrast, moderate FGF-2 concentrations increased the number of vessels: with 0.5 ng/ml FGF-2 it was 1.4-fold higher after DIV 3 or 1.5-fold after DIV 7 compared with controls; with 5 ng/ml it was almost doubled in both cases. With an excess of 50 ng/ml, FGF-2 vessels were reduced after DIV 3 or similar to controls after DIV 7. FGF receptor 1 was preferentially found on endothelial cells; its immunolabeling was reduced in the presence of the ligand. Cell death detected by an ethidium bromide analog or the apoptosis marker caspase-3 was barely detectable during the 10 d culture period. Immunolabeling of the tight junction proteins ZO-1 (zonula occludens protein 1), occludin, claudin-5, and claudin-3 revealed evidence for structural integrity of the bloodbrain barrier in the presence of moderate FGF-2 concentrations. In conclusion, FGF-2 maintains blood vessels in vitro and preserves the composition of the tight junction. Hence, we propose FGF-2-treated organotypic cortical slices as a new tool for mechanistic studies of the bloodbrain barrier.
Key words: bloodbrain barrier; FGF-2; occludin; ZO-1; claudin-3; claudin-5
Received April 15, 2006;
revised Feb. 15, 2007;
accepted Feb. 18, 2007.
Correspondence should be addressed to Dr. Kerstin Bendfeldt at the above address. Email: kerstin.bendfeldt{at}unibas.ch
This article has been cited by other articles:

|
 |

|
 |
 
J. A. Perez, S. M. Clinton, C. A. Turner, S. J. Watson, and H. Akil
A New Role for FGF2 as an Endogenous Inhibitor of Anxiety
J. Neurosci.,
May 13, 2009;
29(19):
6379 - 6387.
[Abstract]
[Full Text]
[PDF]
|
 |
|